Chenchen Feng, etc.,al. A DirectView focus reduction assay for high-throughput quantification of neutralizing antibodies against influenza A and B viruses. Cell Reports Method
Robust and scalable measurement of neutralizing antibodies is critical for influenza surveillance, vaccine development, and outbreak preparedness. Although focus reduction assay (FRA) is widely used to quantify neutralizing antibodies against influenza viruses, its application is limited by labor-intensive immunostaining workflows that restrict throughput. These limitations are particularly challenging when large sample sets must be analyzed during seasonal epidemics or emerging outbreaks caused by high pathogenicity avian influenza viruses. We sought to develop a streamlined assay that preserves the accuracy of FRA while reducing complexity and enabling high-throughput implementation. By leveraging neuraminidase activity as a direct readout of infection, DirectView-FRA addresses these bottlenecks and expands the practical utility of FRA.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 4 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 4 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 4 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 4 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 4 hours ago
[Go Top] [Close Window]


